All News

COVID-19 vaccines have been available for 6 months in the US under FDA EUAs. Many people stepped up ASAP; some remain in the wait and see camp. A new KFF survey parses motivation.

The recent CDC analysis is also one of the first to demonstrate that mRNA vaccines can benefit people who get COVID-19 despite being fully or partially vaccinated.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.

The first nonsteroidal mineralocorticoid receptor antagonist to be approved for adults with T2D-associated CKD fills a significant treatment void for millions of patients.

In the largest study of its kind, patients with COVID-19 who did not receive flu vaccine were significantly more likely to visit the emergency department and to have a stroke, among other severe effects.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.

A recent study found that the use of statins in patients with newly diagnosed T2D reduced incidence of cardiovascular disease and death, particularly among older patients.

These 14 states likely have more than one thing in common, and in the context of COVID-19, probably a few. Editors came across this unfortunate stat today.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.

The most recent update to NIH COVID-19 Treatment Guidelines incorporates RCT data on use of antivirals, immunomodulators, and colchicine as treatment for SARS-CoV-2 infection.

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

Global confirmed deaths due to COVID-19 have surpassed 4 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map and the CDC.

Tezepelumab, a novel human monoclonal antibody that shows promise to reduce exacerbations across asthma phenotypes, was granted FDA Priority Review.

The SGLT-2 inhibitor class, originally approved as antihyperglycemic agents for T2D, has proven "pluripotent," adding indications for related conditions. Test your knowledge of a few basic facts.

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with obesity specialist, Sandra Christensen, MSN, ARNP.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.

Empagliflozin, already indicated to improve outcomes in patients with HFrEF, reduced risk of a composite of CV death or hospitalization for HF in adults HFpEF, marking a potential therapeutic milestone.

A 32-year-old woman is seen in the ED with pain from an ankle injury sustained about 24 hours earlier. What does the x-ray show? How would you proceed?